Drugs · Entity Annotation Prototype (beta)

4articles mentioning drugs

20drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

IL-17i

This drug is selected. Its supporting articles are shown below.

4 articles · page 1 of 1

rmdopen · abstract · 2026-06-16 · 12 matching annotations

95.5%

…ween CRP level and treatment retention among patients receiving IL-17i (intermediate CRP: HR 0.96, 95% CI 0.68 to 1.19; high CRP: HR 0…

bmjimm · abstract · 2026-06-05 · 3 matching annotations

94.3%

…0.91) and fibrosis or cirrhosis (HR 0.81; 95% CI 0.70 to 0.92). IL-17i (4579 matched pairs) and TNFi (15 007 matched pairs) treatment …

rmdopen · abstract · 2025-07-22 · 3 matching annotations

80.3%

…n rate and improvement in all disease activity outcomes suggest ixekizumab as a viable option for patients with multiple b/tsDMARD failure…

bmjopen · abstract · 2026-07-15 · 2 matching annotations

90.4%

…is (PsA) with a clinical indication for treatment escalation of methotrexate (MTX) (ie, non-response or intolerance to MTX) to a b-DMARD are…